AMAG Pharmaceuticals, Inc. (AMAG)


Stock Price Forecast

Nov. 13, 2020


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading AMAG Pharmaceuticals, Inc. chart...

About the Company

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

440

CEO

Scott D. Myers

Exchange

NASDAQ

Website

http://www.amagpharma.com

$301M

Total Revenue

440

Employees

$468M

Market Capitalization

-2.03

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $AMAG News

Activist Fund Manager Ups Stake in Amag Pharma to Stop Merger With Allos

12y ago, source: TheStreet.com

Hedge fund manager Martin Shkreli now own 5% of Amag and is seeking to replace directors to stop a planned merger with Allos Therapeutics. Hedge fund manager Martin Shkreli now own 5% of Amag and ...

AMAG Pharmaceuticals Completes Divestment of Women’s Health Assets

1mon ago, source: ADVFN

AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced AMAG and Palatin Technologies, Inc. have mutually terminated the January 2017 license agreement pursuant to which AMAG was granted ...

Why This New FDA-approved Drug Vyleesi Is Not 'Female Viagra'

4y ago, source: Forbes

Another difference between Vylessi, which will be marketed by AMAG Pharmaceuticals, and Viagra is their routes of administration. Viagra goes into your mouth, or at least you it should ...

Covis Group Announces Agreement to Acquire AMAG Pharmaceuticals

21d ago, source: ADVFN

Covis Group S.à r.l. (“Covis”) and AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that they have entered into a definitive agreement under which Covis will acquire AMAG for $13.75 ...

FDA pulls preterm-birth drug Makena and its generics from market after 12 years

11mon ago, source: Hosted on MSN

The U.S. Food and Drug Administration said Thursday it had reached a final decision to fully withdraw approval of preterm-birth drug Makena and its generics, a full 12 years after the treatment ...

Contact AMAG Technology, Inc.

6y ago, source: SourceSecurity

AMAG Technology is a provider of fully integrated security solutions throughout the world, protecting everything from small offices and schools to large multi-national organizations and high security ...

Madrigal Prices Upsized Public Offering Of $600 Mln Of Shares

6h ago, source: Business Insider

(RTTNews) - Madrigal Pharmaceuticals, Inc. (MDGL), a company focused on nonalcoholic steatohepatitis, said that it has priced its upsized public offering of 750,000 shares at $260 per share and ...

Guardant Health Inc (GH)

14d ago, source: Investing

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) incurred a loss of $1.28 per share in the second quarter of 2019, much wider than the Zacks Consensus Estimate of a loss of 66 cents as ...

Amylyx Pharmaceuticals Inc AMLX

3d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Ionis Pharmaceuticals Inc IONS

4d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Sodium-Potassium Seesaw: Help Patients Balance

12y ago, source: Medscape

Both the medical and lay literature have entertained much discussion about the role of diet in general and sodium intake specifically to minimize population risk for cardiovascular disease and ...

PCSA Processa Pharmaceuticals, Inc.

4d ago, source: Seeking Alpha

Processa Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing the chemotherapy drugs to improve the safety and efficacy of cancer treatment. Its drugs are ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...